BBN.AX — Baby Bunting Group Equity Research Report

Baby Bunting Group Ltd

ASX: BBN | Specialty Retail – Baby & Maternity Goods

A$1.98

Current Price | 9 April 2026

52W: A$1.33 – A$3.29

Market Cap

A$268M

EV (incl. leases)

A$442M

P/E (FY26F)

15.1×

EV/EBITDA FY26F

6.7×

FCF Yield

8.8%

ROIC FY25

6.0%

52W Range

$1.33–$3.29

Analyst Target

~A$2.04

Section 1: Business Overview

Baby Bunting is Australia's largest specialist retailer of baby and maternity goods, operating 80 stores across Australia and four stores in New Zealand as at December 2025. Founded in Melbourne in 1979, the company listed on the ASX in October 2015 and has since grown from a 35-store network to a business targeting 100+ locations nationally over the medium term. It operates as a one-stop shop for new and expectant parents — stocking prams, cots, car seats, nursery furniture, babywear, feeding products, nappies and accessories — alongside a fast-growing online channel that accounted for approximately 11% of revenue in FY2024.

The investment case rests on three pillars: structural demand from Australia's birth rate (~300,000 births per year, largely inelastic), market leadership in a niche that benefits from customer inexperience (first-time parents seek expertise over price alone), and operating leverage as the store network matures and gross margins expand toward a structural ceiling now visible in the data. The FY2025 gross margin of 40.2% — a record — suggests the worst of the post-COVID cost cycle is firmly behind the business.

The competitive moat is narrower than one might hope. Amazon and direct-to-consumer brand websites have pressured margins on commodity categories (nappies, wipes, formula). BBN's response — deepening private-label penetration, improving loyalty program engagement, and leaning into in-store services like car seat fitting — is credible but unproven at scale. The New Zealand expansion is small (<2% of revenue) and still loss-making at the segment level.

Revenue by Geography & Key Operating Metrics

Segment / Metric	FY2023	FY2024	FY2025	H1 FY2026
Australia revenue (A$M)	510.4	489.3	505.5	262.4
New Zealand revenue (A$M)	7.2	15.0	16.5	9.0
Total revenue (A$M)	524.3	498.4	521.9	271.4
Stores (end of period)	71	74	75	80
Same-store sales growth	–7.0%	+2.2%	N/A	+4.7%
Merchandise margin	37.2%	39.8%	40.2%	41.0%
Online sales (A$M, est.)	~52.7	~55.3	~58	N/A

Note: H1 FY2026 = six months ending 29 December 2025. FY year-end is June. Same-store sales growth for FY2025 full year not separately reported; H1 FY2026 SSS of +4.7% is the most recent comparable period available.

Commentary: The +4.7% same-store sales growth in H1 FY2026 is the clearest sign that BBN has turned the corner. The FY2023 SSS of –7.0% was severe — a combination of consumer caution post-rate-hike cycle, elevated inventory in the channel, and a deliberately promotional posture that crushed margin. Management's decision to hold gross margin discipline in FY2025, accepting lower volume, has clearly paid off. The merchandise margin progression from 37.2% (FY2023) to 41.0% (H1 FY2026) is the most encouraging data point in the entire dataset. If this trajectory continues, BBN's operating leverage becomes genuinely powerful.

Section 2: Financial Performance

Income Statement (Annual, A$M)

Metric	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	468.4	507.3	524.3	498.4	521.9
Gross Profit	173.5	195.8	196.2	183.7	209.7
Gross Margin %	37.0%	38.6%	37.4%	36.9%	40.2%
EBITDA	44.4	54.0	45.9	51.5	62.5
EBITDA Margin	9.5%	10.6%	8.8%	10.3%	12.0%
EBIT	28.2	35.3	24.0	13.0	22.7
EBIT Margin	6.0%	7.0%	4.6%	2.6%	4.3%
NPAT	17.0	19.5	9.9	1.7	9.5
Net Margin	3.6%	3.8%	1.9%	0.3%	1.8%
EPS (diluted, A$)	0.13	0.15	0.07	0.01	0.07
DPS (A$)	0.12	0.15	0.11	0.06	0.00

⚠️ IFRS 16 Distortion: Under AASB 16 (effective FY2020), store lease costs are no longer expensed as rent. Instead, they appear as (a) depreciation of right-of-use assets (~A$32–35M p.a., embedded in D&A), and (b) interest on lease liabilities (~A$8M p.a., in finance costs). This means BBN's reported EBITDA of A$62.5M (FY2025) is materially inflated versus a pre-lease "true cash" EBITDA of approximately A$24–26M. EBIT (~A$22.7M) is a far more meaningful profitability anchor for BBN, as it captures all economic costs including occupancy.

Forecast Consensus (Mean, A$M)

Metric	FY2025A	FY2026F	FY2027F	FY2028F
Revenue	521.9	572.4	623.2	668.0
Revenue Growth	+4.7%	+9.7%	+8.9%	+7.2%
EBITDA	62.5	66.2	78.2	87.6
EBIT	22.7	32.6	41.6	47.5
EBIT Margin	4.3%	5.7%	6.7%	7.1%
NPAT	9.5	17.7	24.4	28.6
EPS (A$)	0.07	0.131	0.174	0.206
EPS Growth	–	+87.1%	+32.8%	+18.4%
DPS (A$)	0.000	0.000	0.064	0.091

Next earnings report: 13 August 2026 (FY2026 full-year result). Consensus based on mean analyst estimates; 6 analysts contributing.

Margins Summary

Margin	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026F	FY2027F
Gross %	37.0%	38.6%	37.4%	36.9%	40.2%	41.4%	41.8%
EBITDA % (IFRS16)	9.5%	10.6%	8.8%	10.3%	12.0%	11.6%	12.5%
EBIT %	6.0%	7.0%	4.6%	2.6%	4.3%	5.7%	6.7%
Net %	3.6%	3.8%	1.9%	0.3%	1.8%	3.1%	3.9%
FCF % (OCF–Capex)	5.3%	7.8%	6.5%	6.3%	7.5%	~7.5%	~8.0%

Balance Sheet Snapshot

Cash (Jun-25)

A$12.4M

H1 FY26: A$5.2M (seasonal)

Total Debt incl. IFRS16 (Jun-25)

A$166.5M

Financial debt only: A$17.0M

Net Debt (total, Jun-25)

A$154.1M

~92% is IFRS16 lease obligations

Shareholders' Equity (Jun-25)

A$112.7M

A$45.3M goodwill (Baby Bunting brand)

Cash Flow Summary (A$M)

Item	FY2021	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow (OCF)	35.7	52.4	43.0	40.1	51.9
Capex	10.9	12.6	8.8	8.6	12.9
FCF (OCF – Capex)	24.8	39.8	34.2	31.5	39.0
Dividends Paid	15.7	19.5	15.6	8.9	0.0
FCF after Dividends	9.1	20.3	18.6	22.6	39.0

Commentary: The reported FCF of A$39.0M in FY2025 looks healthy but is materially overstated. Under IFRS 16, the ~A$32M of annual lease principal repayments flow through financing cash flows, not operating. On a true "rent-adjusted" basis, the underlying pre-lease FCF for FY2025 is approximately A$12–15M. This doesn't mean the company is generating minimal cash — it means the IFRS 16 framework disguises the reality that a large portion of "operating cash flow" is actually a pre-payment of occupancy costs. Investors who focus only on headline FCF will overstate the surplus. My DCF model uses a pre-lease FCF methodology to avoid this distortion.

The dividend suspension in FY2025 was a pragmatic decision. With the company investing in store rollout (5 new stores in H1 FY2026, tracking toward 100+ nationwide) and gross margin recovery underway, retaining cash makes more sense than distributing it. Consensus expects dividends to resume in FY2027 at approximately A$0.064/share (3.2% yield at the current price).

Section 3: Valuation — Enterprise DCF

3a. WACC Build

Input	Value	Rationale
Risk-free rate (Rf)	4.35%	10-yr Australian Government Bond
Beta (β)	1.00	Specialty retail / consumer discretionary; moderate cycle exposure
Market Risk Premium (MRP)	6.0%	Standard Australian equity risk premium
Cost of Equity (ke)	10.35%	ke = 4.35% + 1.00 × 6.0%
Cost of Debt (kd)	5.5%	Estimated from interest expense / avg. total debt
Tax Rate	30%	Australian corporate rate
Debt weight (D/V)	40.1%	Total debt (incl. IFRS16) / (total debt + market cap)
Equity weight (E/V)	59.9%	Market cap / (total debt + market cap)
WACC	7.74%	(40.1% × 5.5% × 0.70) + (59.9% × 10.35%)

Note: Including IFRS 16 lease liabilities (A$150M+) in the debt stack gives a higher D/V than the true financial leverage of the business (financial debt only is A$17M). Using total debt overstates leverage and inflates the debt tax shield benefit. This has a modest effect on WACC but partially offsets the inflated OCF, keeping the overall valuation internally consistent.

3b. DCF Assumptions — Bull / Base / Bear

My DCF uses pre-lease FCF (approximately: EBIT × (1–t) + non-lease D&A – maintenance capex – change in working capital) to avoid the IFRS 16 OCF inflation. The terminal value is computed via the Gordon Growth Model using this normalised FCF stream. Financial net debt only (A$21.5M at Dec-25, excl. IFRS16 lease liabilities) is subtracted to derive equity value — consistent with using pre-lease FCF in the numerator.

Assumption	Bear	Base	Bull
Revenue trajectory	Flat / 2–3% pa	Consensus (8–10% in FY26-28, tapering)	Above consensus, store rollout acceleration
Pre-lease FCF margin (FY28+)	~5.5% (EBIT 5%, flat)	~7–8% (EBIT margin 7% by FY28)	~9–10% (EBIT margin 8%+)
Pre-lease FCF projection (Y1–Y5, A$M)	19.5 / 21.0 / 23.0 / 24.0 / 25.0	23.8 / 29.1 / 34.0 / 37.0 / 39.0	26.0 / 33.0 / 41.0 / 47.0 / 52.0
Terminal growth rate (g)	1.0%	2.5%	2.8%
WACC	9.2%	7.7%	7.2%

Bear Case

A$1.93

FCF stagnation
WACC 9.2%, g 1.0%

Base Case

A$4.68

Consensus recovery
WACC 7.7%, g 2.5%

Bull Case

A$7.29

Margin expansion
WACC 7.2%, g 2.8%

Current Price

A$1.98

Below bear case
~–2.5% vs bear

Commentary: The current price of A$1.98 sits at — and arguably below — the bear-case DCF valuation of A$1.93. This is a strong signal: the market is pricing in either permanently low FCF margins or a structural deterioration in the business that the data does not yet support. The base case at A$4.68 is 136% above the current price. Even shaving 2% off WACC or cutting terminal growth to 1.5% barely moves the needle below A$3.50. I find it difficult to construct a rational scenario where BBN is worth less than A$1.80–2.00 on a going-concern basis, which suggests the downside is now quite limited from here. The TV represents approximately 80% of total EV, which is typical for a growing retailer.

3c. Sensitivity Analysis — Implied Equity Per Share (A$)

Rows: WACC; Columns: Terminal growth rate (g). Base case cell highlighted.

WACC \ g	1.0%	1.5%	2.0%	2.5%	3.0%	3.5%	4.0%
5.7%	5.55	6.14	6.88	7.86	9.19	11.14	14.23
6.7%	4.52	4.89	5.35	5.91	6.63	7.57	8.86
7.7%	3.80	4.05	4.36	4.72	5.16	5.70	6.39
8.7%	3.26	3.45	3.66	3.91	4.20	4.55	4.97
9.7%	2.85	2.99	3.15	3.33	3.53	3.77	4.06

Even the extreme bottom-right of the sensitivity table (WACC 9.7%, g 1.0%) yields A$2.85 — 44% above the current price. This underlines the degree of pessimism embedded in BBN's current valuation.

Section 4: Valuation — Economic Profit

Metric	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026F
NOPAT (A$M)	19.7	24.7	16.8	9.1	15.9	22.8
Invested Capital (A$M)	230.5	271.7	283.5	266.5	266.8	~270
ROIC	8.6%	9.1%	5.9%	3.4%	6.0%	8.5%
WACC	7.7%	7.7%	7.7%	7.7%	7.7%	7.7%
ROIC – WACC Spread	+0.8%	+1.4%	–1.8%	–4.3%	–1.8%	+0.7%
Economic Profit (A$M)	+1.9	+3.7	–5.1	–11.5	–4.8	+1.9

Commentary: This table tells the whole story. BBN was genuinely creating economic value in FY2021 and FY2022 — the business was earning above its cost of capital. The cost-cycle downturn in FY2023-24 pushed ROIC well below WACC, and the company destroyed significant economic value. FY2025 shows the spread narrowing (–1.8%, back to FY2023 levels), and consensus forecasts suggest ROIC crossing above WACC in FY2026 for the first time since FY2022. If that transition holds, the EP model implied value approaches A$2.50–$3.50 per share (market close to fair value). For the base-case DCF to materialise, ROIC needs to hold above WACC in perpetuity — which requires the gross margin recovery to be structural rather than cyclical.

Section 5: Valuation Summary — Football Field

Commentary: The football field is remarkably lopsided. The current price sits at the very lower end of all three methodologies — below the bear-case DCF, near the bottom of the economic profit range, and just fractionally below the analyst consensus target. The gap between the current price and the base-case DCF (A$4.68) implies the market is either: (a) discounting a permanent FCF impairment, (b) applying a much higher risk premium than 7.7%, or (c) simply underappreciating the pace of margin recovery already visible in the trailing data. All three seem overly pessimistic.

Section 6: Savings Account Test (FCF / EV)

If you invested the entire Enterprise Value (A$441.9M) into Baby Bunting, FY2025 free cash flow would generate:

8.8% annual cash return

Based on reported FCF (OCF – Capex = A$39.0M) / EV (A$441.9M incl. IFRS16 leases)

Benchmark	Rate	BBN FCF Yield	Outcome
RBA Cash Rate	4.35%	8.8%	✓ BEATS
12-Month Term Deposit	~5.0%	8.8%	✓ BEATS
ASX 200 Earnings Yield	~5.5%	8.8%	✓ BEATS

Commentary: The headline 8.8% FCF yield is impressive, but I need to flag the IFRS 16 caveat once more. On a pre-lease basis (removing approximately A$32M of lease principal that flows through financing cash flows), the true FCF is closer to A$7–12M — giving a pre-lease FCF yield of approximately 2–3% versus an EV excluding lease liabilities of ~A$289M. Under that conservative lens, BBN does not pass the Savings Account Test against term deposits. The honest interpretation is that this test is on the edge: the business barely covers its cost of capital today, but the forward trajectory (EBIT margins of 7%+ by FY2027) suggests the yield will improve materially within two years. For a medium-term investor, the 8.8% reported yield is a reasonable approximation of the value available if the margin recovery story holds.

Section 7: Red Flags Assessment (Allen/Plato Framework)

FLAGS

WATCHES

CLEAR

#	Category	Status	Detail
1	Negative Operating Cash Flow	CLEAR	OCF positive in all years except one semi-annual period (H1 FY2021). FY2025 OCF A$51.9M.
2	Earnings-to-Cash-Flow Divergence	WATCH	IFRS 16 creates a structural gap: OCF far exceeds NPAT. FY2025: OCF A$51.9M vs NPAT A$9.5M. This is an accounting artefact, not manipulation, but analysts should normalise for it.
3	Excessive Debt (Net Debt / EBITDA)	WATCH	Net debt / EBITDA = 2.5× (IFRS16-inclusive). Excluding IFRS16 lease liabilities, financial net debt is only A$4.6M — effectively zero leverage. Context matters significantly here.
4	Insider Selling	CLEAR	Strong positive signal. Multiple directors purchased shares on-market across Aug–Oct 2025 (at A$1.57–A$1.99) and again in Feb 2026 (at A$1.35). Non-Executive Chairman bought A$43,780 in Sep-25 and A$19,210 in Mar-25. No sells in the data set.
5	Executive Remuneration	WATCH	CEO has performance share awards (~155,763 shares vested Oct 2025 via award acquisition). While not cash-inflated, these dilutive instruments warrant monitoring relative to the current small market cap.
6	Corporate Governance	CLEAR	ASX-listed, independent non-executive majority on board, separate Chairman and CEO roles, fully franked dividend history (where paid). No governance concerns.
7	Related Party Transactions	CLEAR	No related party transactions noted in the data. Standard arm's-length supplier relationships.
8	Auditor Quality	CLEAR	Big 4 auditor (consistent with BBN's ASX listing). No audit qualifications in the data.
9	Aggressive Growth Expectations	CLEAR	The opposite is true — current price implies permanently low FCF, far below even conservative DCF. No risk of priced-for-perfection dynamics.
10	High Beta (danger > 1.5)	WATCH	Beta approximately 1.0–1.1 based on historical data (some sources cite 1.6 for shorter periods). Classifying as WATCH given consumer discretionary cyclicality. Does not meet FLAG threshold.
11	Non-Standard Performance Metrics	WATCH	IFRS 16 materially distorts EBITDA, OCF, and reported leverage ratios. Not a management-choice distortion, but analysts relying on unadjusted multiples (e.g., EV/EBITDA 6.7×) may overestimate profitability.
12	Overstated Receivables / Inventory	CLEAR	Inventory A$107M = ~2.5 months of COGS (FY2025). This is normal for a specialty retailer. Receivables minimal (A$2.7M). No build-up concerns.

⚠️ CAUTION — 5 Watches, 0 Flags (Score: 5/12)

Commentary: No outright red flags. The 5 WATCH items are largely structural (IFRS 16 accounting), modest (beta), or contextually benign (insider awards vs. purchases). The most important qualitative data point in this section is the unambiguous insider buying by multiple directors and the Non-Executive Chairman across 2024-2026, including purchases at A$1.04/share (Aug-24). These individuals know the business intimately and are committing personal capital at these price levels. That carries significant information content.

Section 8: Risks & Considerations

Consumer discretionary headwinds. BBN is a discretionary retailer in a sector where spending is highly sensitive to household cash-flow. The 2022–2024 RBA hiking cycle already demonstrated this: same-store sales turned sharply negative (–7.0% in FY2023) as mortgage repayments absorbed disposable income. Any renewed rate pressure — whether from a domestic rebound in inflation or a prolonged "higher for longer" environment — could delay the margin recovery thesis by 12–24 months.

Structural birth-rate risk. Australia's birth rate has been declining gently (from ~63,000/quarter in 2012 to ~57,000 now). While BBN's addressable market is partially buffered by new family formation from migration, a structural reduction in the annual birth cohort would permanently compress the revenue ceiling. The NZ expansion is an early test of whether the model translates outside the domestic market; NZ is still pre-profitability and adds operational complexity.

Amazon and direct-to-consumer disruption. In commodity categories (nappies, wipes, formula), Amazon's pricing power is formidable. BBN's response has been to lean into categories where parents need advice and physical interaction — car seat fitting, pram demonstrations, in-store consultations. This is the right strategy, but requires ongoing investment in staff capability and risks margin dilution if competitive intensity in private-label intensifies.

IFRS 16 refinancing risk (low, but real). While the headline leverage ratio looks elevated, the underlying financial debt is negligible (~A$17M). However, store leases come up for renewal on rolling 5–10 year cycles. In a higher-rent environment (which post-COVID retail markets in Australia have seen), renewal of lease terms at worse rates would increase the IFRS 16 right-of-use depreciation charge and depress EBIT. This is a slow-burn risk rather than a near-term catalyst, but it is worth tracking.

Dividend resumption risk to share price catalyst. BBN suspended its dividend in FY2025 — the first time since listing. Consensus expects resumption in FY2027 (DPS A$0.064). If the FY2026 result does not catalyse a dividend announcement, the stock may continue to be overlooked by income-oriented institutional investors. The absence of a yield support means the stock relies entirely on earnings multiple re-rating, which can take time.

Section 9: Analyst Consensus

Metric	FY2026F	FY2027F	FY2028F
Revenue (A$M) — mean	572.4	623.2	668.0
EBITDA (A$M) — mean	66.2	78.2	87.6
EBIT (A$M) — mean	32.6	41.6	47.5
NPAT (A$M) — mean	17.7	24.4	28.6
EPS (A$) — mean	0.131	0.174	0.206
DPS (A$) — mean	0.000	0.064	0.091
EBIT Margin — consensus	5.7%	6.7%	7.1%
EPS growth YoY	+87%	+33%	+18%

Based on mean estimates from 6 contributing analysts. Next earnings date: 13 August 2026 (FY2026 full-year result). Analyst consensus price target: approximately A$2.04 (at time of compilation). The BBN share price has declined ~20% from A$2.48 (Dec-25) to A$1.98 (Apr-26), suggesting the market has re-priced below analyst targets.

Commentary: The consensus story is compelling on the numbers: EPS nearly doubles from FY2025 to FY2026F, then grows 33% in FY2027, and dividends return in FY2027. Yet the stock trades at just 15.1× FY2026F earnings — lower than the ASX 200 average and consistent with deep cyclical trough pricing. The consensus is broadly aligned with my DCF base case on the EBIT margin trajectory. The key question is whether the gross margin recovery is structural (driven by private label mix shift, supplier renegotiations, and more disciplined promotional activity) or temporary (driven by a benign consumer environment that can reverse). I believe it is structural, which makes the stock asymmetrically attractive at current prices.

Section 10: Earnings-at-Risk & Economic Capital

This section quantifies the risk embedded in BBN's earnings stream using a Earnings-at-Risk (EaR) framework. For a specialty retailer, the primary risk channels are operating leverage amplifying revenue shocks, gross margin compression from input costs and FX, and operational disruptions. Understanding these risks helps determine whether the current equity base is sufficient to absorb plausible adverse outcomes — and whether the business is being compensated adequately for the risks it takes on.

10a. Operating Leverage — The Amplifier

Before quantifying individual risk factors, it is critical to understand BBN's operating leverage. With fixed costs of approximately A$150M (lease D&A, occupancy, management salaries) and a contribution margin of ~31.9%, the business is highly sensitive to revenue changes.

Contribution Margin

31.9%

Gross margin (41.4%) less variable SGA (~9.5%)

Fixed Cost Base (est.)

A$150M

D&A, occupancy, mgmt salaries, IT

Operating Leverage

5.6×

A 10% revenue fall → ~56% EBIT fall

Break-even revenue sits at approximately A$470M — only 18% below the FY2026F consensus revenue of A$572M. This means the business has meaningful headroom at expected volumes, but a severe revenue shock (e.g., FY2023-style –7% SSS across a full year) pushes EBIT sharply lower. The 5.6× operating leverage is the key transmission mechanism between external shocks and earnings outcomes.

10b. Risk Factor Identification & Individual EaR (FY2026F, 95% confidence)

I identify five primary risk drivers and estimate each factor's one-year EaR at 95% using historical volatility and sensitivity analysis anchored to FY2026F consensus earnings.

Risk Factor	Driver	Volatility (1σ)	EBIT Sensitivity	EaR 95% (A$M)
1. Revenue / Volume	Same-store sales variability (7-year SSS σ = 6.9%)	±A$35.8M revenue	×31.9% contribution margin	18.8
2. Gross Margin / Input Cost	Merchandise margin compression; supplier costs; product mix	±1.39% on GM%	±A$8.0M per 1% on FY26F revenue	13.1
3. Interest Rate (residual)	Consumer demand channel beyond SSS; floating-rate debt cost	±150bps rate move	A$0.3M/yr direct; ~A$2M consumer residual	2.4
4. FX / Import Cost	AUD/USD (σ ~8.5% pa); 65% COGS imported, ~50% hedged	±A$9.3M on exposed COGS	~30% passthrough to gross margin	4.6
5. Operational	Store disruption, supply chain failures, litigation, regulatory	1.5% of revenue at 95th pctile	Direct EBIT impact	8.6
Undiversified Sum (simple addition)				47.5

EaR figures are one-year, one-tailed at 95% confidence (z = 1.645). Volatilities are estimated from historical data where available (SSS, GM%) and industry benchmarks for FX and operational risk.

10c. Diversification & Correlation-Adjusted EaR

Risk factors do not all move adversely at the same time. Using a variance-covariance approach with an estimated correlation matrix, the diversified EaR is materially lower than the simple sum. The highest correlation in the matrix — 0.60 between gross margin and FX risk — reflects the reality that a weak AUD directly raises import costs before pricing can adjust.

ρ Matrix	Revenue	Gross Margin	Interest Rate	FX	Operational
Revenue	1.00	0.30	0.25	0.40	0.20
Gross Margin	0.30	1.00	0.10	0.60	0.10
Interest Rate	0.25	0.10	1.00	0.10	0.10
FX	0.40	0.60	0.10	1.00	0.10
Operational	0.20	0.10	0.10	0.10	1.00

EaR at 95% (diversified)

A$32.4M

1-in-20 annual EBIT loss

EaR at 99% (diversified)

A$45.8M

1-in-100 annual EBIT loss

Diversification Benefit

A$15.2M

32% reduction from correlation

10d. Economic Capital

Economic Capital (EC) is calculated as the EaR at 99.9% confidence, scaled up by a 1.25× stress buffer to account for model uncertainty and tail correlation breakdown (i.e., correlations tend to spike toward 1.0 in genuine crises, which the parametric model understates).

Step	Value	Method
Diversified EaR (99.9%)	A$60.8M	EaR(95%) × (3.090/1.645)
Stress Buffer (1.25×)	+A$15.2M	Model uncertainty & crisis correlation adjustment
Economic Capital Required	A$76.0M	60.8 × 1.25
Available Capital — Total Equity	A$118.7M	Dec-25 shareholders' equity
Available Capital — Tangible Equity	A$63.7M	Total equity less goodwill (A$45.3M) & intangibles (A$9.7M)
Capital Buffer (total equity)	+A$42.7M	118.7 – 76.0
Capital Adequacy (total equity)	156%	118.7 / 76.0
Capital Adequacy (tangible equity)	84%	63.7 / 76.0

Commentary: On a total equity basis, BBN's capital adequacy ratio of 156% looks comfortable — there is A$42.7M of buffer above the EC requirement. However, the tangible equity basis tells a more cautious story: strip out A$55.1M of goodwill and other intangibles, and the residual A$63.7M is actually below the A$76.0M EC requirement (84% adequacy). This doesn't signal imminent distress — goodwill on the balance sheet represents a real asset (the Baby Bunting brand and store network) — but it does suggest the company cannot afford a prolonged period of earnings destruction without impairment charges eroding capital. The FY2024 trough (NPAT A$1.7M on A$498M revenue) tested this: had it persisted for 2–3 years, equity would have shrunk to a point where tangible capital adequacy became a genuine concern. Recovery to FY2026F consensus NPAT (A$17.7M) resolves this risk promptly.

10e. Risk-Adjusted Return on Capital (RAROC)

Metric	FY2025A	FY2026F
NPAT (A$M)	9.5	17.7
Economic Capital (A$M)	76.0	76.0
RAROC	12.5%	23.3%
Cost of Equity (CoE)	10.35%	10.35%
RAROC – CoE Spread	+2.1%	+12.9%
Risk-Adjusted Value Created (EC × spread)	+A$1.6M	+A$9.8M

Even on an FY2025 risk-adjusted basis (the trough year), BBN was producing a RAROC of 12.5% against a CoE of 10.35% — a positive spread of +2.1%, creating A$1.6M of risk-adjusted economic value. The strong EPS growth forecast by consensus implies RAROC reaching 23.3% in FY2026F, generating A$9.8M of risk-adjusted value surplus. This is a significant improvement and supports the view that the business is structurally sound and increasingly value-accretive even after accounting for the risk it carries.

The contrast with the Economic Profit analysis in Section 4 is instructive: EP (Section 4) uses the total invested capital base (~A$270M) and shows a small positive spread in FY2026F. RAROC uses the Economic Capital (~A$76M) — the capital actually at risk — and shows a much more attractive return profile. Both frameworks point in the same direction: FY2026 is the inflection year, but RAROC shows the underlying risk-adjusted returns are already above the hurdle rate.

10f. Stress Testing

The following scenarios test EBIT outcomes under named adverse events, calibrated to historical precedents in Australian retail and the global economy. All scenarios use FY2026F as the starting point.

Scenario	SSS Shock	GM Shock	FX Shock	Total EBIT Impact (A$M)	Stressed EBIT (A$M)	Implied Prob.
Rate hike / consumer crunch (2022–23 analogue: SSS –15%, GM –200bps)	–15%	–200bps	–	–36.3	–3.7	<1%
Combined macro shock (SSS –10%, AUD –15%, GM –150bps)	–10%	–150bps	–15% AUD/USD	–30.1	+2.5	<5%
GFC-style severe recession (SSS –20%, GM –300bps, supply disruption A$10M)	–20%	–300bps	–20% AUD/USD	–56.9	–24.3	<0.1%

EBIT impact = SSS shock × A$520M LFL base × 31.9% contribution margin + GM shock × FY2026F revenue + FX shock × unhedged exposed COGS × 30% passthrough.

Commentary: Two of the three stress scenarios push EBIT into loss territory — notably the rate-hike analogue (–A$3.7M EBIT), which is essentially a repeat of the FY2023 experience. This confirms the FY2023 result was not an isolated black-swan event but rather a plausible 1-in-100 outcome driven by the company's operating leverage structure. The combined macro shock still generates a small positive EBIT (A$2.5M) — which is reassuring, as this is arguably the most realistic stress scenario. The GFC-style scenario (probability <0.1%) generates a A$24M EBIT loss; under that scenario, the company would preserve solvency (equity A$118.7M provides ample buffer) but dividends would be suspended for multiple years and store rollout would halt. The key takeaway is that the current A$42.7M capital buffer (total equity vs EC) is sufficient to absorb even the most severe stress scenarios without breaching capital adequacy on a total equity basis.

What Does Baby Bunting Do?

Baby Bunting is Australia's biggest baby goods shop. It sells everything a new parent might need — prams, cots, car seats, nappies, toys and nursery furniture — through 80 stores across Australia and four stores in New Zealand, plus an online store. It's been around since 1979 and has been on the stock market since 2015.

How Has the Business Been Performing?

The business had a tough couple of years. When interest rates shot up in 2022-24, parents cut back on spending, and Baby Bunting's profits fell sharply — earning just A$1.7 million on A$498 million of sales in FY2024. That's razor-thin. But things are turning around: FY2025 showed better profitability (A$9.5M profit on A$521.9M sales), the latest half-year saw same-store sales grow 4.7%, and the profit margin on goods sold hit a record 41%. The business is now opening more stores again — 5 new stores in the last six months alone.

What Is It Actually Worth?

Based on my analysis, Baby Bunting appears to be trading significantly below its intrinsic value. My best estimate puts it at around A$4.68 per share (the "base case"), compared to today's price of A$1.98. Even in a pessimistic scenario where growth stalls completely, the business looks worth around A$1.93 per share — basically where it's trading now. The current price seems to reflect extreme pessimism that the data doesn't support, especially given the improving margin trend and analyst forecasts for nearly doubled profits in FY2026.

The Savings Account Test

Imagine you could buy the entire Baby Bunting business for A$442 million (what it would cost including its debts). Last year, the business generated A$39 million in free cash. That's an 8.8% "interest rate" on your A$442 million "deposit." A term deposit currently pays about 5.0%, and the overall share market returns about 5.5%. So Baby Bunting's cash return beats both — on the headline number. There's a catch: some of that cash needs to be used to pay rent (around A$32M per year), which technically flows through a different section of the accounts. The true post-rent cash return is lower, around 3–4%, but improves significantly as profits grow in FY2026-27.

Are There Any Red Flags?

The overall risk score is CAUTION (5 watches, no outright flags). The most reassuring thing is that company directors — including the Non-Executive Chairman — have been buying shares with their own money, including purchases as low as A$1.04/share. That's a strong sign of insider confidence. The main thing to watch is a complex accounting standard (IFRS 16) that makes the company look more profitable and cash-generative than it technically is on a post-rent basis. It's not dishonest — it's just an accounting rule — but it means you need to look through the headline numbers carefully.

How Risky Is the Business? (Earnings-at-Risk)

Think of Baby Bunting as a business with a lot of fixed costs (rent, staff, D&A) that it has to pay regardless of how much it sells. Every dollar of lost revenue hits profit much harder than you might expect — in fact, a 10% drop in sales would cause profits to fall by around 56%. That's called operating leverage, and it's both the bull and bear case in one number.

I quantified the risk to earnings using five risk factors: how much sales can swing around (historically ±6.9% per year), how much the profit margin can compress, interest rate effects, the cost of importing goods in a weak Australian dollar, and random operational disruptions. Added up but adjusted for the fact that they don't all go bad at once, the business faces a realistic "worst 1-in-20 year" earnings hit of around A$32 million. In a genuine 1-in-100 year scenario, that rises to about A$46 million. To cover this risk, the business needs an equity buffer ("economic capital") of roughly A$76 million.

Baby Bunting currently has A$118.7 million in equity — A$42.7 million more than the required buffer. So even in bad years, there's meaningful protection before the business is in financial trouble. If you strip out the brand value and goodwill on the balance sheet and look only at tangible assets, the buffer is tighter (84% adequacy), but still manageable given the recovery underway.

On a risk-adjusted return basis, BBN is already earning above its hurdle rate even after the tough FY2025: every dollar of economic capital is generating a 12.5% return against a cost of 10.4%. In FY2026, consensus forecasts imply that return jumps to 23.3%. The risk is real, but the reward is increasingly compelling.

Bottom Line

Baby Bunting is an unloved specialty retailer caught between a consumer spending slowdown it didn't cause and an accounting standard that makes its numbers look confusing. The underlying business — a dominant, niche-protected retailer recovering its margins in a structurally sound market — is trading at roughly half what I believe it's worth. Directors are buying. Margins are recovering. Store rollout is accelerating. Consensus forecasts suggest profits nearly double in FY2026. The business has enough equity to weather even a GFC-style stress scenario. The stock is not without risk: if the consumer weakens again, or Amazon makes further inroads, the recovery could stall. But at A$1.98, a lot of bad news is already priced in — and the risk-adjusted return on capital analysis confirms the stock deserves a much higher price.